E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts

Clinical prognosis of metastasized colorectal carcinoma (CRC) is still not at desired levels and novel drugs are needed. Here, we focused on the multi-tyrosine kinase inhibitor E7080 (Lenvatinib) and assessed its therapeutic efficacy against human CRC cell lines in vitro and human CRC xenografts in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neoplasia
Main Authors: Wiegering, Armin, Korb, Doreen, Thalheimer, Andreas, Kämmerer, Ulrike, Allmanritter, Jan, Matthes, Niels, Linnebacher, Michael, Schlegel, Nicolas, Klein, Ingo, Ergün, Süleyman, Germer, Christoph-Thomas, Otto, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4240916/
https://ncbi.nlm.nih.gov/pubmed/25425971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.09.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados